European Innovation Partnership on Active & Healthy Ageing : A new initiative in service of Preventive Health Planning and Adherence

1

The European Commission Innovation

Partnership on Active and Healthy Ageing

has called on the public and private

sectors to join forces in support of

improving and protecting senior health in

the EU.

Sanofi Pasteur MSD, the leading vaccine

company in Europe, is responding with an

initiative aiming to improve seniors’

adherence to prescriptions and medical

plans.

Specifically, the new initiative aims to

tackle a major cause of disease in the

elderly: immunosenescence, or the

decline of immune function with age.

Seniors are at higher risk of catching and

2

suffering severely from infectious

diseases due to immunosenescence and

multiple health conditions.

The initiative will establish a state-of-the-

art, expert-furnished web portal to

educate and inform health care

professionals and seniors about

preventive health options, and provide

personalized tools to empower good

choices in nutrition and vaccination.

Sanofi Pasteur MSD is committed to

bring together the right expertise across

the continent behind this cause,

including the Commission partners and

new public health institutions and

industry partners at national and regional

levels.

+

European  Innovation  Partnership  on  Active  and  Healthy  Ageing  

2

+

The Challenge

The Focus on Prevention Sanofi Pasteur MSD has joined the European Innovation Partnership on Active and Healthy Ageing as the first vaccine industry partner. The company’s project focuses on prevention of health issues related to the aging body’s naturally weakening immune system (immunosenescence). The project will bring together medical experts, public health institutions and diverse and innovative industries to provide seniors and their care givers with information, education and personalized health tools that will foster good choices, including nutrition and vaccination.

The European population is aging rapidly. The

number of people over 65 will double in the next 50

years, and the number of people over 80 will triple.

The anticipated economic impact is significant. By

2020, there will be only two active citizens in Europe

for each retiree, down from a four-to-one ratio today.

What’s worse, people are living longer, but not more

healthfully with about 20% of their life spent in ill

health.

The Solutions

The European Innovation Partnership on Active and

Healthy Ageing connects and catalyzes public and

private sectors behind this challenge. Partners work

on projects to deliver social, technological, and

organizational innovation with the goal of increasing

the healthy lifespan of EU citizens by 2 years.

The partnership focuses on three pillars:

• Improving quality of life for seniors • Supporting health care system sustainability • Fostering economic growth and EU industry

competitiveness through innovation

European  Innovation  Partnership  on  Active  and  Healthy  Ageing  

3

Unique. Trusted.

Personalised. A New Resource for Seniors and their Health Care Providers

1

The project initiated by Sanofi Pasteur MSD

will deliver a new and unique preventive

health resource to individuals and their health care providers.

The web-based platform will feature

educational and personalised preventive

health information for seniors, with content

tailored to each European countries and

cultures. It will include information about

vaccination, nutrition and other preventive

health tips to help prevent the consequences

of immunosenescence.

Respected geriatricians, infectiologists,

nutritionists and various expert will furnish

content to ensure quality and reliability of

information.

An innovative, proven « expert » IT system

developed by a French start-up will provide

users with personalised recommendations

based on their individual profiles.

Over time, the platform will also offer users

the opportunity to create and securely share

a personalized, preventive electronic health

record with information about subjects like

immunisation and nutrition.

Health authority endorsement of the

platform’s content will be key to its success.

The platform will be developed and tested in

pilot EU sites with an anticipated launch in Q4

2014.

Through the platform, health care providers

will receive high-quality, European-

2

recognised training on immunosenescence

and prevention, which will encourage good

practice habits and communication skills.

The highly educational nature of the platform

will also contribute to better patient health

literacy, empowering individuals to be actors

and take responsibility for their health and

increasing their willingness to be protected

from preventable infectious diseases.

With both health care providers and patients

better informed on the same health topic, the

physician-patient relationship can improve,

increase trust, efficiency, and compliance

with health-related actions.

Through better understanding of

immunosenescence and use of

prevention methods, the project will

contribute to promoting active and healthy ageing of our European senior

citizens while containing healthcare

expenditures.

Several partners have already shown high

interest in joining the initiative : The

University of Maastricht, geriatricians,

infectiologists, nutritionists, the former WHO

coordinator of vaccine R&D, and two

innovative start-ups : one in IT systems and

one for advocacy marketing (Q3 AMP).

Additional partners will be gathered through

the EIP in the coming months.

+

European  Innovation  Partnership  on  Active  and  Healthy  Ageing  

4

+ For More Information :

General Information :

• The European Innovation Partnership on Active and Healthy Ageing: ec.europa.eu/active-healthy-ageing ec.europa.eu/health/ageing/innovation/marketplace/

• Sanofi Pasteur MSD :

spmsd.com

For more information or to participate in the immunosenescence initiative:

Sibilia QUILICI Senior Manager, Health Policy Sanofi Pasteur MSD 8, rue Jonas Salk 69367 Lyon Cedex 07 – France Tel : +33 4 37 28 4717 Mob : +33 6 07 81 4997

European  Innovation  Partnership  on  Active  and  Healthy  Ageing